Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib
- PMID: 33005718
- PMCID: PMC7519269
- DOI: 10.1016/j.jdcr.2020.07.054
Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib
Keywords: IL, interleukin; JAK, Janus kinase.
Figures
References
-
- Thornsberry L.A., English J.C. Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. Am J Clin Dermatol. 2013;14(4):279–290. - PubMed
-
- Piette E.W., Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016;75(3):467–479. - PubMed
-
- Rosenbach M. Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders. J Am Acad Dermatol. 2020;82(3):e91–e92. - PubMed
-
- Wang J., Khachemoune A. Granuloma annulare: a focused review of therapeutic options. Am J Clin Dermatol. 2018;19(3):333–344. - PubMed
Publication types
LinkOut - more resources
Full Text Sources